These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30907435)

  • 21. [Facial palsy sequel and botulinum toxin].
    Benichou L; Labbe D; Le Louarn C; Guerreschi P
    Ann Chir Plast Esthet; 2015 Oct; 60(5):377-92. PubMed ID: 26432177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.
    Boroojerdi B; Ferbert A; Schwarz M; Herath H; Noth J
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):111-4. PubMed ID: 9667571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
    Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
    Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years.
    Streitová H; Bareš M
    Acta Neurol Belg; 2014 Dec; 114(4):285-91. PubMed ID: 24604684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of the Facial Lines Treatment Satisfaction Questionnaire and initial results for botulinum toxin type A-treated patients.
    Cox SE; Finn JC; Stetler L; Mackowiak J; Kowalski JW
    Dermatol Surg; 2003 May; 29(5):444-9; discussion 449. PubMed ID: 12752509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital Image Speckle Correlation to Optimize Botulinum Toxin Type A Injection: A Prospective, Randomized, Crossover Trial.
    Verma R; Klein G; Xu Y; Rafailovich M; Gilbert Fernandez JJ; Khan SU; Bui DT; Dagum AB
    Plast Reconstr Surg; 2019 Jun; 143(6):1614-1618. PubMed ID: 31136474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines.
    Sommer B; Zschocke I; Bergfeld D; Sattler G; Augustin M
    Dermatol Surg; 2003 May; 29(5):456-60. PubMed ID: 12752511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin to improve lower facial symmetry in facial nerve palsy.
    Sadiq SA; Khwaja S; Saeed SR
    Eye (Lond); 2012 Nov; 26(11):1431-6. PubMed ID: 22975654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Botulinum Toxin Therapy Improve Quality of Life in Patients with Facial Palsy?
    Fuzi J; Taylor A; Sideris A; Meller C
    Aesthetic Plast Surg; 2020 Oct; 44(5):1811-1819. PubMed ID: 32700008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of the cosmetic treatment of facial muscles with a new botulinum toxin.
    Wiest LG
    Acta Dermatovenerol Croat; 2009; 17(1):48-53. PubMed ID: 19386215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: Repartition and kinetics of doses used.
    Risoud M; Aljudaibi N; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2016 Feb; 61(1):10-5. PubMed ID: 25953657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of botulinum toxin a in the establishment of symmetry in pediatric paralysis of the lower lip.
    Haykal S; Arad E; Bagher S; Lai C; Hohman M; Hadlock T; Zuker RM; Borschel GH
    JAMA Facial Plast Surg; 2015; 17(3):174-8. PubMed ID: 25742503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aesthetic indications for botulinum toxin injection.
    Guyuron B; Huddleston SW
    Plast Reconstr Surg; 1994 Apr; 93(5):913-8. PubMed ID: 8134483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
    Dolar Bilge A; Sadigov F; Salar-Gomceli S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.